"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente Medical Center Lab Drawing Station conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Medical Center Lab Drawing Station" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Medical Center Lab Drawing Station" are "BRCA 1 Gene Mutation" (1 trials), "BRCA 2 Gene Mutation" (1 trials), "Breast Neoplasms" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Kaiser Permanente Medical Center Lab Drawing Station" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Medical Center Lab Drawing Station" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bicalutamide" (1 trials), "Enzalutamide" (1 trials), "Physician's-Choice" (1 trials) and "talazoparib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Medical Center Lab Drawing Station" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Medical Center Lab Drawing Station". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kaiser Permanente Medical Center Lab Drawing Station, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Medical Center Lab Drawing Station, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".